SIREN : 505251470
RAISON DE SANTE is a French company founded 17 years ago, specialized in the sector Activités des agences de publicité. Based in PUTEAUX (92800), this company of category GE shows in 2024 a revenue of 2.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 144 987 € | 2 063 862 € | 2 098 526 € | 1 928 197 € | 1 538 147 € | 1 582 620 € | 1 763 970 € | 1 574 699 € | 1 568 680 € |
| Net income | 26 996 € | -32 679 € | 71 164 € | 54 378 € | 74 061 € | 29 648 € | 52 495 € | 87 820 € | 57 138 € |
| EBITDA | 129 082 € | 10 587 € | 131 785 € | 95 665 € | 116 846 € | 64 831 € | 80 533 € | 116 639 € | 62 462 € |
| Net margin | 1.3% | -1.6% | 3.4% | 2.8% | 4.8% | 1.9% | 3.0% | 5.6% | 3.6% |
In 2024, RAISON DE SANTE achieves revenue of 2.1 M€. Revenue is growing positively over 9 years (CAGR: +4.0%). Vs 2023: +4%. After deducting consumption (0 €), gross margin stands at 2.1 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 129 k€, representing 6.0% of revenue. Positive scissor effect: EBITDA margin improves by +5.5 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 27 k€, i.e. 1.3% of revenue. This profit can be retained or distributed to shareholders.
2 144 987 €
2 144 987 €
129 082 €
23 852 €
26 996 €
6.0%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory. Cash flow represents 1.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
0.0%
34.472%
1.898%
0.0
8.4%
In 2024, the debt ratio of RAISON DE SANTE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of RAISON DE SANTE (34.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of RAISON DE SANTE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 172.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.
172.875
0.143
In 2024, the liquidity ratio of RAISON DE SANTE (172.88) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of RAISON DE SANTE (0.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 108 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 161 days. Excellent situation: suppliers finance 53 days of the operating cycle (retail model). Inventory turnover is 24 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 191 days of revenue, i.e. 1.1 M€ to permanently finance. Over 2016-2024, WCR increased by +23%, requiring additional financing.
1 138 602 €
108 j
161 j
24 j
191 j
Based on 68 transactions of similar company sales
(all years),
the value of RAISON DE SANTE is estimated at
345 597 €
(range 120 927€ - 1 034 994€).
With an EBITDA of 129 082€, the sector multiple of 2.9x is applied.
The price/revenue ratio is 0.22x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 68 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare RAISON DE SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des agences de publicité
The revenue of RAISON DE SANTE in 2024 is 2.1 M€.
Yes, RAISON DE SANTE generated a net profit of 27 k€ in 2024.
The headquarters of RAISON DE SANTE is located in PUTEAUX (92800), in the department Hauts-de-Seine.
The tax return of RAISON DE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
RAISON DE SANTE operates in the sector Activités des agences de publicité (NAF code 73.11Z). See the 'Sector positioning' section above to compare the company with its competitors.